The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Two alumni of the Tri-Institutional MD-PhD Program were awarded the 2018 Scholar Awards from the American Society of Hematology (ASH). Aaron Goldberg, MD, PhD (class of 2011) and Carlos Villa, MD, PhD (class of 2012) each received one of the most prestigious awards the ASH offers, valued at $100,000 each.Read more information on the award.
Sixth year MD-PhD student Alex Perez has been named to Forbes 30 Under 30 list for his work on using computational techniques to better understand cancer. He completed his PhD in Dr. christina Leslie and Andrea Ventura's labs at Memorial Sloan Kettering.